These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4831652)

  • 21. Ouabain-induced myocardial catecholamine release: inhibition by propranolol.
    Ciofalo F; Treece G
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):73-9. PubMed ID: 4686110
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
    Jaillon P; Hecklé J; Weissenburger J; Cheymol G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
    Côté P; Polumbo RA; Harrison DC
    Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of propranolol on haemodynamic parameters and myocardial blood flow during acute anoxia in dogs.
    Skolasińska K; Sandor P; Tomaszewicz H; Zurowski S
    Acta Physiol Pol; 1973; 24(1):159-63. PubMed ID: 4716338
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 29. The actions of histamine on the mammalian heart.
    Flacke W; Atanacković D; Gillis RA; Alper MH
    J Pharmacol Exp Ther; 1967 Feb; 155(2):271-8. PubMed ID: 6025518
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beta-adrenergic receptor blockade on coronary haemodynamics in the resting unanaesthetized dog.
    Pitt B; Green HL; Sugishita Y
    Cardiovasc Res; 1970 Jan; 4(1):89-92. PubMed ID: 4392025
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog.
    Branch RA; Shand DG; Nies AS
    J Pharmacol Exp Ther; 1973 Oct; 187(1):133-7. PubMed ID: 4746322
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of beta sympathetic blockade on the initial hemodynamic response to exercise.
    Smulyan H; Eich RH
    J Lab Clin Med; 1968 Mar; 71(3):378-89. PubMed ID: 4868950
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of increased afterload on the inotropic state and uptake of free fatty acids in the intact dog heart.
    Kjekshus J; Mjos OD
    Acta Physiol Scand; 1972 Mar; 84(3):415-27. PubMed ID: 5019038
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 36. Digitalis. I.
    Smith TW; Haber E
    N Engl J Med; 1973 Nov; 289(18):945-52. PubMed ID: 4591305
    [No Abstract]   [Full Text] [Related]  

  • 37. Coronary and systemic hemodynamic effects of propranolol and practolol compared in the resting, conscious dog.
    Andres JF; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):481-4. PubMed ID: 4818387
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hemodynamic effect of glucagon on the intact dog heart].
    Fricke GR; Simon H; Esser H
    Arch Kreislaufforsch; 1971; 64(1):98-114. PubMed ID: 4397043
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of the haemodynamic effects of propranolol, 4-hydroxypropranolol and practolol in anaesthetized dogs.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1972 Jun; 45(2):207-17. PubMed ID: 4403100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial effects of imidazole.
    Knope R; Moe GK; Saunders J; Tuttle R
    J Pharmacol Exp Ther; 1973 Apr; 185(1):29-34. PubMed ID: 4693184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.